REGN

REGENERON PHARMACEUTICALS

REGN·75886F107·US·Common Stock·Healthcare - Biotechnology-13D/G

REGN (REGENERON PHARMACEUTICALS) is held by 314 institutional investors as of Q2 2026. Largest holders: BlackRock, Inc. ($5.7B), VANGUARD CAPITAL MANAGEMENT LLC ($4.1B), DODGE & COX ($3B). Net institutional sentiment: Mixed. In Q2 2026, 7 members of Congress and 164 funds bought REGN.

314
Holders
(30 Elite)
$51.1B
Total Value
51% (321)
Consensus
164 buying - 157 selling
13F: Insider & Congress: Updated regularly
REGN

Smart Money Verdict

View all
Loading verdict
Held by 314 funds
30 elite

Who's Trading

Source dates: Price Aug 28, 2026 · Insiders Aug 21, 2026 · Activists Apr 30, 2026 · Congress Jul 21, 2026

InsiderLJLAROSA JOSEPH JTax 9K shAug 19, 2026
InsiderLJLAROSA JOSEPH JExercise 12K shAug 19, 2026
InsiderFRFenimore Christopher R.Tax 5K shAug 18, 2026
Checking access…

Top Holders

Checking access…
Fund
Action
Shares
Value
Weight
Est. P&L
Conviction
Increased
9.1M(+1.9%)$5.7B0.1%+16.83%
32
Decreased
6.6M(-0.4%)$4.1B0.1%+5.74%
0
Increased
4.9M(+9.3%)$3B1.6%+32.18%
55
Increased
4.8M(+3.6%)$3B0.1%-5.30%
33
Increased
3.9M(+0.9%)$2.5B0.2%+11.67%
38
Decreased
3.8M(-12.5%)$2.4B0.1%+26.86%
0
Increased
3.2M(+84.5%)$2B0.1%+15.92%
49
Increased
2.8M(+1.8%)$1.7B0.4%+4.32%
39
Increased
2.6M(+0.7%)$1.6B0.1%+53.03%
32
Decreased
2M(-2.2%)$1.3B0.3%+22.98%
0
Decreased
1.9M(-2.8%)$1.2B1.5%+73.56%
0
Increased
1.4M(+5.9%)$871.5M0.0%-10.21%
34
Increased
1.3M(+8.5%)$805M0.1%+21.36%
34
Decreased
1.3M(-30.9%)$792M0.1%+5.93%
0
Decreased
1.2M(-10.6%)$725.3M0.1%+17.33%
0
Decreased
1.1M(-8.5%)$702.2M0.2%+24.36%
0
Increased
1M(+0.4%)$632M0.2%+10.46%
38
Decreased
916,467(-2.7%)$571.5M0.1%+61.26%
0
Increased
846,306(+5.2%)$527.7M0.1%+46.29%
33
Decreased
831,964(-45.2%)$518.8M0.0%+13.78%
0

Showing 1-20 of 326

1 / 17
REGNREGNREGENERON PHARMACEUTICALS

Other Healthcare stocks held by institutions

Data sourced from four public-disclosure sources: SEC 13F, Form 4, 13D/13G, and House/Senate STOCK Act disclosures. Not financial advice. Full disclaimer

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used